@article{8ce87bd45f384497952fce031811475a,
title = "AsthmaMap: An interactive knowledge repository for mechanisms of asthma",
keywords = "Asthma, data interpretation, disease map, disease mechanisms, knowledge representation",
author = "Alexander Mazein and Olga Ivanova and Irina Balaur and Marek Ostaszewski and Valeriya Berzhitskaya and Tatiana Serebriyskaya and Thomas Ligon and Jan Hasenauer and \{de Meulder\}, Bertrand and Overall, \{Rupert W.\} and Ludovic Roy and Knowles, \{Richard G.\} and Wheelock, \{Craig E.\} and Sven-Erik Dahlen and Chung, \{Kian Fan\} and Adcock, \{Ian M.\} and Graham Roberts and \{U-BIOPRED study group\} and \{eTRIKS Consortium\} and Ratko Djukanovic and Johann Pellet and Piotr Gawron and Rudi Balling and \{Maitland-van der Zee\}, \{Anke H.\} and Reinhard Schneider and Sterk, \{Peter J.\} and Charles Auffray",
note = "Funding Information: The AsthmaMap project progresses in alliance with the efforts of the Disease Maps Community (https://disease-maps.org). Disclosure of potential conflict of interest: S.-E. Dahlen reports personal fees from AstraZeneca, Boehringer-Ingelheim, Cayman Chemicals, GlaxoSmithKline (GSK), Novartis, Regeneron, Roche, Sanofi, and Teva outside the submitted work. K. F. Chung has received honoraria for participating in advisory board meetings of GSK, AstraZeneca, Roche, Novartis, Merck, BI, TEVA, and Shionogi regarding treatments for asthma, chronic obstructive pulmonary disease, and chronic cough and has also been remunerated for speaking engagements. R. Balling is a founder and a shareholder of MEGENO S.A. and a shareholder of ITTM S.A. R. Djukanovic reports receiving fees for lectures at symposia organized by Novartis, AstraZeneca, and TEVA; consultation for TEVA and Novartis as member of advisory boards; participation in a scientific discussion about asthma organized by GSK; and is a cofounder and current consultant and has shares in Synairgen, a University of Southampton spin-out company. A. H. Maitland-van der Zee reports grants and personal fees from Boehringer Ingelheim and GSK, grants from Vertex, and personal fees from AstraZeneca, all paid to her institution, and, in a public-private partnership, sponsored by Health Holland matching grants from Boehringer Ingelheim, Breathomix, Fluidda, Ortec Logiqcare, Philips, Quantib-U, Smartfish, SODAQ, Thirona, TopMD, and Novartis outside the submitted work. R. Schneider is a founder and a shareholder of MEGENO S.A. and ITTM S.A. P. J. Sterk is a scientific adviser and officially has a nonsubstantial interest in the start-up company Breathomix BV, which produces eNoses and accompanying cloud algorithms. The rest of the authors declare that they have no relevant conflicts of interest.",
year = "2021",
month = mar,
doi = "10.1016/j.jaci.2020.11.032",
language = "English",
volume = "147",
pages = "853--856",
journal = "Journal of allergy and clinical immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "3",
}
SDG 3 Good Health and Well-being